TrialDiabetes, obesity & metabolism2009

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.

J Jendle et al.PubMed ↗Publisher ↗

No numbers read from the abstract.